-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NUujMMbgphL/Y0tY98hQhk4+XtHqmny7bI/l2hE4OFhXFcmDQkuMp6kb/QyjPHir ttax2I1iN5FSMiADrOphXQ== 0001104659-04-004745.txt : 20040217 0001104659-04-004745.hdr.sgml : 20040216 20040217143450 ACCESSION NUMBER: 0001104659-04-004745 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 GROUP MEMBERS: KPCB VIII ASSOCIATES L.P. GROUP MEMBERS: L.JOHN DOERR SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DRUGSTORE COM INC CENTRAL INDEX KEY: 0001086467 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 043416255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-57797 FILM NUMBER: 04607330 BUSINESS ADDRESS: STREET 1: 13920 SE EASTGATE STE 300 CITY: BELLEVUE STATE: WA ZIP: 98005 BUSINESS PHONE: 4258815131 MAIL ADDRESS: STREET 1: 13920 SOUTHEAST EASTGATE WAY STREET 2: SUITE 300 CITY: BELLEVUE STATE: WA ZIP: 98005 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KLEINER PERKINS CAUFIELD & BYERS VIII LP CENTRAL INDEX KEY: 0001032458 IRS NUMBER: 770431351 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 4152332750 MAIL ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13G/A 1 a04-2508_1sc13ga.htm SC 13G/A

 

 

UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION

OMB Number:
3235-0145

 

Washington, D.C. 20549

Expires:
December 31, 2005

 

SCHEDULE 13G

Estimated average burden hours per response. . 11

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)

Under the Securities Exchange Act of 1934
(Amendment No.  4)(1)

 

drugstore.com, inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

262241102

(CUSIP Number)

 

December 31, 2003

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

o

Rule 13d-1(c)

ý

Rule 13d-1(d)

 


(1)           The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No.  262241102

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Kleiner Perkins Caufield & Byers VIII, L.P., a California limited partnership (“KPCB VIII”) 77-0431351

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

ý

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
California limited partnership

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
10,130,403

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
10,130,403

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
10,130,403

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
14.39%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

2



 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
KPCB VIII Associates, L.P., a California limited partnership (“KPCB VIII Associates”) 94-3240818

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

ý

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
California limited partnership

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
10,717,207 shares of which 10,130,403 shares are directly held by KPCB VIII and 586,804 shares are directly held by KPCB VIII Founders Fund, L.P., a California limited partnership ("KPCB VIII FF").  KPCB VIII Associates is the general partner of KPCB VIII and KPCB VIII FF.

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
10,717,207 shares of which 10,130,403 shares are directly held by KPCB VIII and 586,804 shares are directly held by KPCB VIII FF.  KPCB VIII Associates is the general partner of KPCB VIII and KPCB VIII FF.

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
10,717,207

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
15.22%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

3



 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
L. John Doerr

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

ý

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United States

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,025,738 shares, of which 12,500 are options which are fully vested.

 

6.

Shared Voting Power
11,068,745 shares of which 10,130,403 shares are directly held by KPCB VIII, 586,804 shares are directly held by KPCB VIII FF and 351,538 shares are directly held by KPCB Life Sciences Zaibatsu Fund II, L.P., a California limited partnership (“KPCB ZF II").  KPCB VIII Associates is the general partner of KPCB VIII and KPCB VIII FF.  KPCB VII Associates, L.P., a California limited partnership (“KPCB VII Associates”), is the general partner of KPCB ZF II. Mr. Doerr is a general partner of KPCB VIII Associates and KPCB VII Associates.  Mr. Doerr disclaims beneficial ownership of the shares held directly by KPCB VIII, KPCB VIII FF and KPCB ZF II.

 

7.

Sole Dispositive Power
1,025,738 shares, of which 12,500 are options which are fully vested.

 

8.

Shared Dispositive Power
11,068,745 shares of which 10,130,403 shares are directly held by KPCB VIII, 586,804 shares are directly held by KPCB VIII FF and 351,538 shares are directly held by KPCB ZF II.  KPCB VIII Associates is the general partner of KPCB VIII and KPCB VIII FF.  KPCB VII Associates is the general partner of KPCB ZF II. Mr. Doerr is a general partner of KPCB VIII Associates and KPCB VII Associates.  Mr. Doerr disclaims beneficial ownership of the shares held directly by KPCB VIII, KPCB VIII FF and KPCB ZF II.

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
12,094,483

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
17.18%

 

 

12.

Type of Reporting Person (See Instructions)
IN

 

4



 

Item 1.

 

(a)

Name of Issuer
drugstore.com, Inc.

 

(b)

Address of Issuer’s Principal Executive Offices
13920 SE Eastgate Way, Suite 300
Bellevue, WA 98005

 

Item 2.

 

(a)

Name of Person Filing
Kleiner Perkins Caufield & Byers VIII, L.P., a California limited partnership

KPCB VIII Associates, L.P., a California limited partnership

L. John Doerr

 

(b)

Address of Principal Business Office or, if none, Residence
c/o Kleiner Perkins Caufield & Byers

2750 Sand Hill Road, Menlo Park, California 94025

 

(c)

Citizenship
The entities listed in 2(a) are California limited partnerships.  The individuals listed in 2(a) are United States citizens.

 

(d)

Title of Class of Securities
Common Stock

 

(e)

CUSIP Number
262241102

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g)

o

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

(h)

o

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

5



 

 

(j)

o

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Not applicable.

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)

Amount beneficially owned:   

 

 

(b)

Percent of class:   

 

 

(c)

Number of shares as to which the person has:

 

 

 

(i)

Sole power to vote or to direct the vote   

 

 

 

(ii)

Shared power to vote or to direct the vote    

 

 

 

(iii)

Sole power to dispose or to direct the disposition of   

 

 

 

(iv)

Shared power to dispose or to direct the disposition of   

 

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

Not Applicable

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Under certain circumstances set forth in the limited partnership agreements of KPCB VIII, KPCB VIII FF and KPCB ZF II, the general and limited partners of such entities may have the right to receive dividends on, or the proceeds from the sale of, the securities of drugstore.com, inc. held by such entity.  No such partner's rights relate to more than five percent of the class.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group

Not Applicable

 

Item 9.

Notice of Dissolution of Group

Not Applicable

 

Item 10.

Certification

Not Applicable

 

6



 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 14, 2004

 

L. JOHN DOERR

KPCB VIII ASSOCIATES, L.P., A
CALIFORNIA LIMITED PARTNERSHIP

 

 

 

 

 

 

Signature

/s/ SUSAN BIGLIERI

 

Signature

/s/ BROOK H. BYERS

 

 

Susan Biglieri,

 

Brook H. Byers,

 

Attorney-in-Fact

 

A General Partner

 

 

 

 

 

 

KLEINER PERKINS CAUFIELD & BYERS
VIII, L.P., A CALIFORNIA LIMITED
PARTNERSHIP

 

 

 

 

 

 

 

 

By:   KPCB VIII Associates, L.P., a California
Limited Partnership, its General Partner

 

 

 

 

 

 

 

 

Signature

/s/ BROOK H. BYERS

 

 

 

 

Brook H. Byers,

 

 

 

A General Partner

 

7



 

EXHIBIT INDEX

 

Exhibit

 

Found on
Sequentially
Numbered Page

 

 

 

Exhibit A:  Agreement of Joint Filing

 

9

 

 

 

Exhibit B:  List of General Partners of KPCB VIII Associates

 

10

 

8



 

EXHIBIT A

 

Agreement of Joint Filing

 

The undersigned hereby agree that they are filing jointly pursuant to Rule 13d-1 of the Act the statement dated February 14, 2004 containing the information required by Schedule 13G, for the securities of drugstore.com, inc., held by Kleiner Perkins Caufield & Byers VIII, L.P., a California limited partnership, and with respect to the general partners, such other holdings as may be reported therein.

 

 

Date:       February 14, 2004

 

L. JOHN DOERR

KPCB VIII ASSOCIATES, L.P., A
CALIFORNIA LIMITED PARTNERSHIP

 

 

 

 

 

 

Signature

/s/ SUSAN BIGLIERI

 

Signature

/s/ BROOK H. BYERS

 

 

Susan Biglieri,

 

Brook H. Byers,

 

Attorney-in-Fact

 

A General Partner

 

 

 

 

 

 

 

 

 

 

KLEINER PERKINS CAUFIELD & BYERS
VIII, L.P., A CALIFORNIA LIMITED
PARTNERSHIP

 

 

By:   KPCB VIII Associates, L.P., a
California Limited Partnership, its General
Partner

 

 

 

 

 

 

 

 

 

 

 

Signature

/s/ BROOK H. BYERS

 

 

 

 

Brook H. Byers,

 

 

 

A General Partner

 

9



 

EXHIBIT B

 

General Partners of
KPCB VIII Associates, a California Limited Partnership

 

Set forth below, with respect to each general partner of KPCB VIII Associates, is the following: (a) name; (b) business address; and (c) citizenship.

 

1.

(a)  Brook H. Byers*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

2.

(a)  Kevin R. Compton*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

3.

(a)  L. John Doerr*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

4.

(a)  William R. Hearst III*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

5.

(a)  Vinod Khosla*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

6.

(a)  Joseph S. Lacob*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 

 

7.

(a)  Douglas J. Mackenzie*

 

(b)  c/o Kleiner Perkins Caufield & Byers

 

2750 Sand Hill Road

 

Menlo Park, CA 94025

 

(c)  United States Citizen

 


* Listed individual is also a general partner of KPCB VII Associates, L.P., a California limited partnership.

 

10


-----END PRIVACY-ENHANCED MESSAGE-----